and, to some degree, assess susceptibility to pyrazinamide (3).
Characterization of Mycobacterium orygis
To the Editor: We thank Gey van Pittius and colleagues for their addition to the markers that identify Mycobacterium orygis as a distinct subspecies in the M. tuberculosis complex (1) . Its isolation from a wild buffalo broadens the host range of M. orygis. Gey van Pittius and colleagues raise 3 issues: the utility of the gyrB oryx single-nucleotide polymorphism (SNP) being equally specific as the reported SNP in Rv2042 38 , the presence of genomic regions RD701 and RD702 in M. orygis, and the addition of the sequence type (ST) 701 spoligotype to M. orygis-specific spoligotypes.
We With the added data, we can conclude that M. orygis is an M. tuberculosis complex subspecies defined by the presence of genomic regions RD1, RD2, RD4, RD5a, RD6, RD13-RD16, RD701, and RD702, by the C-to-G SNP in mmpL6
551
, and by the deletion of regions RD3, RD5b, RD7-RD12, RDoryx_1, RDoryx_4, and RDoryx_wag22. Subspeciesspecific SNPs are present in gyrB and Rv2042. Spoligotypes ST587, ST701, and closely related types are characteristic of M. orygis, and this subspecies yields 17-20 copies of insertion sequence 6110 and a distinct 24-locus variable number tandem repeats pattern (4, 5) . Given the rapid progress in genome sequencing, additional markers specific for the different subspecies will further enrich this panel of differences. (3, 4) . Of note, the Beijing 2002-1585 strain, for which frequency of mutation to rifampin resistance is 10 -3 CFU (1 mutant/1,000 CFU), showed a moderate frequency of 10 −8 CFU in another study (4) . We think that a mutation frequency increase of 100,000× is remarkably high. In contrast, rifampinresistant mutants of the Beijing 1585 strain did not emerge in low-density cultures (5 × 10 5 CFU/mL) used for time-kill kinetics experiments, although frequency of mutation to rifampin resistance was determined to be 10 -3 CFU. Mutation frequency is determined by fluctuation assays. To exclude preexisting mutants, which would bias the mutation frequency by so-called jackpots, a series of low-inoculum cultures is typically used (5). However, for unknown reasons, de Steenwinkel et al. used only 1 highdensity culture of 10 10 CFU of each strain to determine mutation frequency. This strategy is not recommended because mutations can occur early or late, resulting in substantial mutation frequency fluctuation between test episodes. A strain with known mutation rates should preferably be included to rule out possible technical errors.
Jakko van Ingen, Roland Brosch, and Dick van Soolingen
We propose the following explanations for the remarkable results: 1) the rifampin concentration for selecting mutants might have been too low, enabling growth of some colonies of drug-susceptible bacteria; 2) rifampin mutants arose early or preexisted in the cultivation of Beijing strains 1585 and 1607, producing jackpots; or 3) the 2 Beijing isolates might contain rifampin-resistant subpopulations (heteroresistance). The capacity of the Beijing strain to develop and, especially, transmit multidrug-resistant tuberculosis remains to be further analyzed. at a subculture concentration of 8 mg/L, whereas we found a mutation frequency of 3-4 × 10 −3 at a subculture concentration of 1 mg/L and a lower mutation frequency at 2 mg/L. Thus, the concentration of drugs in subculture plates is crucial to mutation frequency assays. Absent a subculture concentration standard, we applied rifampin at 1 mg/L (4) because bacteria growing at this concentration are considered resistant to rifampin. Our mutation frequency and time-kill kinetics assay results are not contradictory
Jim Werngren

